Abstract
Mucormycosis is a rare opportunistic fungal infection caused by saprophytic zygomycetes. These fungal infections are caused by members of the mucorales. The clinical importance of zygomycosis, an emerging and frequently fatal mycotic disease, has increased during recent years, due to several risk factors such as (a) the use of broad-spectrum antibiotic, (b) use of empirical antifungal treatment (mainly triazoles), and (c) aggressive chemotherapy and sustained leucopenia (i.e., peripheral stem cell transplantation). An almost fulminant pneumonia caused by Syncephalastrum racemosum in an immunocompromised patient with an aggressive non-Hodgkin lymphoma (NHL) is described. Despite treatment with amphotericin B, deoxycholate, caspofungin, and surgical resection of fungal bodies from both lungs, and survival of 10 months without relapsing from fungal infection, the patient died due to hematological complications from an unresponsive disease. Herein is the description of the first case of pulmonary infection caused by Syncephalastrum racemosum.
References
Gomes MZ, Lewis RE, Kontoyiannis DP. Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor and -Lichtheimia species. Clin Microbiol Rev. 2001;24:411–45.
Schwarz P, Bretagne S, Gantier JC, Garcia-Hermoso D, Lortholary O, Dromer F, Dannaoui E. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol Infect. 2006;44:340–9.
Voigt K, Cigelnik E, O’donnell K. Phylogeny and PCR identification of clinically important zygomycetes based on nuclear ribosomal-DNA sequence data. J Clin Microbiol. 1999;37:3957–64.
Vitale RG, de Hoog GS, Schwarz P, Dannaoui E, Deng S, Machouart M, Voigt K, van de Sande WW, Dolatabadi S, Meis JF, Walther G. Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales. J Clin Microbiol. 2012;50:66–75.
Amatya R, Khanal B, Rijal A. Syncephalastrum producing mycetoma-like lesions. Indian J Dermatol Venereol Leprol. 2010;76:284–6.
Kamalam A, Thambiah AS. Cutaneous infection by Syncephalastrum. Sabouraudia. 1980;18:19–20.
Baradkar VP, Mathur M, Panda M, Kumar S. Sino-orbital infection by Syncephalastrum racemosum in chronic hepatorenal disease. J Oral Maxillofac Pathol. 2008;12:45–7.
Schlebusch S, Looke DF. Intraabdominal zygomycosis caused by Syncephalastrum racemosum infection successfully treated with partial surgical debridement and high-dose amphotericin B lipid complex. J Clin Microbiol. 2005;43:5825–7.
Rao CY, Kurukularatne C, Garcia-Diaz JB, Kemmerly SA, Reed D, Fridkin SK, Morgan J. Implications of detecting the mold Syncephalastrum in clinical specimens of New Orleans residents after Hurricanes Katrina and Rita. J Occup Environ Med. 2007;49:411–6.
Buayairaksa M, Kanoknedhakul S, Kanokmedhakul K, Moosophon P, Hahnvajanawong C, Soytong K. Cytotoxic lasiodiplodin derivatives from the fungus Syncephalastrum racemosum. Arch Pharm Res. 2011;34:2037–41.
Hammond SP, Bialek R, Milner DA, Petschnigg EM, Baden LR, Marty FM. Molecular methods to improve diagnosis and identification of mucormycosis. J Clin Microbiol. 2011;49:2151–3.
Korabečná M, Liška V, Fajfrlík K. Primers ITS1, ITS2 and ITS4 detect the intraspecies variability in the internal transcribed spacers and 5.8S rRNA gene region in clinical isolates of fungi. Folia Microbiol. 2003;48:233–8.
White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, editors. PCR protocols. A guide to methods and applications. San Diego: Academic Press; 1990. p. 315–22.
Zaki SM, Elkholy IM, Elkady NA, Abdel-Ghany K. Mucormycosis in Cairo, Egypt: review of 10 reported cases. Med Mycol. 2014;52:73–80.
Otcenásek M, Buchta V. In vitro susceptibility to 9 antifungal agents of 14 strains of zygomycetes isolated from clinical specimens. Mycopathologia. 1994;128:135–7.
Ramesh V, Ramam M, Capoor MR, Sugandhan S, Dhawan J, Khanna G. Subcutaneous zygomycosis: report of 10 cases from two institutions in north India. J Eur Acad Dermatol Venereol. 2010;24:1220–5.
Pavlovic MD, Bulajic N. Great toenail onychomycosis caused by Syncephalastrum racemosum. Dermatol Online J. 2006;12:7.
Mathuram AJ, Mohanraj P, Mathews MS. Rhino-orbital-cerebral infection by Syncephalastrum racemosusm. J Assoc Physicians India. 2013;61:339–40.
Mangaraj S, Sethy G, Patro MK, Padhi S. A rare case of subcutaneous mucormycosis due to Syncephalastrum racemosum: case report and review of literature. Indian J Med Microbiol. 2014;32:448–51.
Nyilasi I, Papp T, Csernetics Á, Krizsán K, Nagy E, Vágvölgyi C. High affinity iron permease (FTR1) gene sequence based molecular identification of clinically important zygomycetes. Clin Microbiol Infect. 2008;14:393–7.
Conflict of interest
All authors declare to have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rodríguez-Gutiérrez, G., Carrillo-Casas, E.M., Arenas, R. et al. Mucormycosis in a Non-Hodgkin Lymphoma Patient Caused by Syncephalastrum racemosum: Case Report and Review of Literature. Mycopathologia 180, 89–93 (2015). https://doi.org/10.1007/s11046-015-9878-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-015-9878-1